Last reviewed · How we verify
Nebivolol-Test product
At a glance
| Generic name | Nebivolol-Test product |
|---|---|
| Sponsor | Bio-innova Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy (PHASE3)
- Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging (PHASE2)
- Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets (PHASE1)
- Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg (PHASE1)
- ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
- Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet (PHASE1)
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nebivolol-Test product CI brief — competitive landscape report
- Nebivolol-Test product updates RSS · CI watch RSS
- Bio-innova Co., Ltd portfolio CI